The artificial intelligence (AI) model GPT-4, known from its application in ChatGPT, shows impressive capabilities in biomedical research and can be used in many ways for simulations. A simulator developed at MedUni Vienna ...
Jul 11, 2024
0
0
A newly developed molecule, LK-2, could inform new therapies for stroke-related brain injury, find scientists at The Hospital for Sick Children (SickKids).
Jul 10, 2024
0
68
In order to find previously unknown substances for the treatment of chlamydial infections, the scientific team led by Georg Stary (Department of Dermatology at MedUni Vienna, CeMM of the Austrian Academy of Sciences) screened ...
Jul 10, 2024
0
19
A new study, published in the July 10 online issue of Neurology, looks at predicting how quickly people with early Alzheimer's disease will experience cognitive decline. The study also looked at how the new drugs recently ...
Jul 10, 2024
0
28
Older adults who suffer serious injuries from a fall or a motor vehicle accident often have impaired long-term functioning and diminished quality of life. A new study, published in JAMA Surgery by researcher-clinicians from ...
Jul 10, 2024
0
0
Human induced pluripotent stem (hiPS) cells refer to stem cells derived from adult somatic cells like blood or skin cells. hiPS-derived cardiomyocytes (hiPC-CMs) have shown promise in treating ischemic heart disease. However, ...
Jul 10, 2024
0
1
Age-related macular degeneration (AMD) is a leading cause of vision loss in the U.S., affecting 11 million people, particularly older adults. The more severe form, neovascular age-related macular degeneration (nAMD), is characterized ...
Jul 9, 2024
0
18
Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system. Researchers at Linköping University have developed a tool that can predict the risk level ...
Jul 9, 2024
0
39
Researchers from the Hebrew University of Jerusalem have developed a machine learning approach to identify potential subtypes in diseases, significantly enhancing the field of disease classification and treatment strategies. ...
Jul 9, 2024
0
0
A new approach to treating the most malignant type of brain cancer—glioblastoma—has shown strong promise in pre-clinical settings, raising hopes of increasing current average survival rates beyond 18 months.
Jul 9, 2024
0
1
